CAMBRIDGE, Mass.--(BUSINESS WIRE)--Dec. 16, 2005--EPIX Pharmaceuticals, Inc. (NASDAQ: EPIX) announced today that it had hired an interim General Counsel and a strategy health care consulting firm to assist it in the analysis and potential consummation of the acquisition of a smaller biotherapeutics company. Philip Chase has joined the company as Interim Vice President and General Counsel, with primary responsibility for overseeing the acquisition process. Health Advances, LLC, a Weston, Massachusetts-based strategy health care consulting firm, has been hired to assist the Company in commercial market analyses of the candidate companies EPIX is evaluating for acquisition.
